Enhancing Oral Absorption of β-Lapachone: Progress Till Date.
about
Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species.The effect of lycopene on cytochrome P450 isoenzymes and P-glycoprotein by using human liver microsomes and Caco-2 cell monolayer model.
P2860
Enhancing Oral Absorption of β-Lapachone: Progress Till Date.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Enhancing Oral Absorption of β-Lapachone: Progress Till Date.
@en
Enhancing Oral Absorption of β-Lapachone: Progress Till Date.
@nl
type
label
Enhancing Oral Absorption of β-Lapachone: Progress Till Date.
@en
Enhancing Oral Absorption of β-Lapachone: Progress Till Date.
@nl
prefLabel
Enhancing Oral Absorption of β-Lapachone: Progress Till Date.
@en
Enhancing Oral Absorption of β-Lapachone: Progress Till Date.
@nl
P2860
P50
P1476
Enhancing Oral Absorption of β-Lapachone: Progress Till Date
@en
P2093
Isabel Gonzalez-Alvarez
Marta Gonzalez-Alvarez
P2860
P2888
P356
10.1007/S13318-016-0369-7
P577
2017-02-01T00:00:00Z
P6179
1024944198